Salvadori, Maurizio <br/><br/>
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.  [electronic resource] 

 -  Transplantation  Nov 2009 
 - 1194-202 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e3181bb43ec  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Confidence Intervals<br/>Creatinine--blood<br/>Cyclosporine--blood<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Everolimus<br/>Humans<br/>Immunosuppressive Agents--blood<br/>Kidney Transplantation--adverse effects<br/>Living Donors<br/>Middle Aged<br/>Patient Compliance<br/>Patient Selection<br/>Sirolimus--analogs & derivatives<br/>Survival Analysis<br/>Treatment Outcome<br/>Triglycerides--blood<br/>Young Adult